KDR and acute myeloid leukemia: Similarly, in acute myeloid leukaemia (AML), exosomes enriched with vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) messenger RNA enhanced endothelial cell glycolysis and proliferation, leading to the promotion of chemoresistance in AML cells [15].